Abstract
As the hallmark sequelae of juvenile dermatomyositis (JDM), the calcinosis still bothers approximately one third of the patients, but it was considered a good prognostic sign.Today, however, it is universally acknow-ledged that the calcinosis is instead deemed a marker of the special state and inappropriate treatment for JDM.The treatment of based on disease process, including the biological agents and other immunomodulator, which have been not the radical therapy.However, it is a crucial to alleviate the calcinosis that controlling the long-term chronic inflammation for JDM. Key words: Juvenile dermatomyositis; Calcinosis; Mineral-associated proteins; Autoantibody; Chronic inflammation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
